The Grand Duchy of Luxembourg has committed to co-financing the international fight against antimicrobial resistance.
Luxembourg has joined with five other countries- Germany, the Netherlands, the United Kingdom, South Africa and Switzerland- as well as with the British Wellcome Research Foundation to contribute financially to the development of new treatments used in the fight against antimicrobial resistance.
The announcement was made on 4 September 2017 by the German Health Minister Hermann Gröhe and the Secretary of State for Education and Research, Georg Schütte, after a conference of donors in Berlin.
The total amount of funds collected under the impetus of Germany amounts to €56,5 million, of which €100,000 comes from contributions paid by the Ministry of Health and the Directorate for Development Cooperation and Development Humanitarian Action of the Ministry of Foreign and European Affairs. The funds are then sent to GARDP, a joint project of the World Health Organization (WHO) and the DNDi (Drugs for Neglected Diseases Initiative), which aims to develop new treatments for infections concerned with antimicrobial resistance, a plague that is likely to have substantial health benefits at the international level in the near future in the event of inaction.
The Luxembourg Minister of Health Lydia Mutsch welcomed Luxembourg's role in the GARDP partnership, which gave concrete expression to the political commitments made by the international community and thus revitalised the efforts launched under the auspices of the WHO.
